CLCF1
Basic information
Region (hg38): 11:67364168-67374177
Links
Phenotypes
GenCC
Source:
- Cold-induced sweating syndrome 1 (Supportive), mode of inheritance: AR
- cold-induced sweating syndrome (Supportive), mode of inheritance: AR
- cold-induced sweating syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Crisponi/Cold-induced sweating syndrome 2 | AR | Neurologic | In the neonatal/early childhood period, the condition can be lethal unless advanced care is instituted; Later, it has been described that cold-induced sweating was alleviated by medical treatment (eg, with clonidine, with lasting effects when co-administered with amitriptyline) | Musculoskeletal; Neurologic | 16782820; 20400119 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (35 variants)
- not_provided (13 variants)
- Cold-induced_sweating_syndrome_2 (5 variants)
- CLCF1-related_disorder (2 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLCF1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000013246.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | |||||
| missense | 34 | 39 | ||||
| nonsense | 1 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 3 | 0 | 35 | 10 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CLCF1 | protein_coding | protein_coding | ENST00000312438 | 3 | 10010 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.948 | 0.0519 | 125731 | 0 | 4 | 125735 | 0.0000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.12 | 104 | 141 | 0.735 | 0.00000871 | 1438 |
| Missense in Polyphen | 28 | 48.076 | 0.58241 | 526 | ||
| Synonymous | 0.408 | 54 | 58.0 | 0.932 | 0.00000333 | 487 |
| Loss of Function | 2.83 | 0 | 9.32 | 0.00 | 4.86e-7 | 88 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000123 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000178 | 0.0000176 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytokine with B-cell stimulating capability. Binds to and activates the ILST/gp130 receptor. {ECO:0000269|PubMed:10448081, ECO:0000269|PubMed:10500198}.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);Signaling by Interleukins;IL-6-type cytokine receptor ligand interactions;Cytokine Signaling in Immune system;Immune System;Glycerophospholipid metabolism;Interleukin-6 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.248
Intolerance Scores
- loftool
- 0.367
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.380
- hipred
- Y
- hipred_score
- 0.667
- ghis
- 0.460
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clcf1
- Phenotype
- embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- positive regulation of immunoglobulin production;cell surface receptor signaling pathway;JAK-STAT cascade;positive regulation of cell population proliferation;regulation of signaling receptor activity;cytokine-mediated signaling pathway;B cell differentiation;positive regulation of B cell proliferation;positive regulation of tyrosine phosphorylation of STAT protein;negative regulation of neuron apoptotic process;positive regulation of isotype switching to IgE isotypes;positive regulation of astrocyte differentiation
- Cellular component
- extracellular region;CRLF-CLCF1 complex;CNTFR-CLCF1 complex
- Molecular function
- signaling receptor binding;cytokine activity;ciliary neurotrophic factor receptor binding;protein binding;growth factor activity;protein heterodimerization activity